Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Pediatr Diabetes. 2016 Feb 4;18(2):95–102. doi: 10.1111/pedi.12359

Fig. 5.

Fig. 5

Plasma matrix metalloproteinase (MMP)-9 levels are presented for diabetes controls (n = 17), children with diabetic ketoacidosis (DKA) at presentation (time 1) (n = 19), and children with DKA during therapy (time 2) (n = 17). Box plots show the interquartile range (IQR) (shaded box), median (box center line), with fences extending to 1.5 times the IQR. Circulating MMP-9 levels were higher in children with DKA compared with diabetes controls at time 1 (mean 67 vs. 25 ng/mL, p < 0.001) and time 2 (mean = 59 ng/mL, p = 0.009).